191 results on '"Mulligan, RC"'
Search Results
2. Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor flk1
- Author
-
Becker, CM, Farnebo, FA, Iordnanescu, I, Behonick, DJ, Shih, MC, Dunning, P, Christofferson, R, Mulligan, RC, Taylor , GA, Kuo, CJ, Zetter BR, Becker, CM, Farnebo, FA, Iordnanescu, I, Behonick, DJ, Shih, MC, Dunning, P, Christofferson, R, Mulligan, RC, Taylor , GA, Kuo, CJ, and Zetter BR
- Published
- 2002
3. Lentivirus-Based Expression of Human Alpha-1 Antitrypsin Ameliorates Emphysema in Mice.
- Author
-
Wilson, AA, primary, Murphy, GJ, additional, Hamakawa, H, additional, Kwok, L, additional, Srinivasan, S, additional, Hovav, A, additional, Mulligan, RC, additional, Amar, S, additional, Suki, B, additional, and Kotton, DN, additional
- Published
- 2009
- Full Text
- View/download PDF
4. Comparative evaluation of the antitumor activity of antiangiogenicproteins delivered by gene transfer.
- Author
-
Kuo, CJ, Farnebo, F, Yu, EY, Christofferson, R, Swearingen, RA, Carter, R, von Recum, HA, Yuan, J, Kamihara, J, Flynn, E, D'Amato, R, Folkman, J, Mulligan, RC, Kuo, CJ, Farnebo, F, Yu, EY, Christofferson, R, Swearingen, RA, Carter, R, von Recum, HA, Yuan, J, Kamihara, J, Flynn, E, D'Amato, R, Folkman, J, and Mulligan, RC
- Published
- 2001
5. Oligomerization-dependent regulation of motility and morphogenesis by thecollagen XVIII NC1/endostatin domain.
- Author
-
Kuo, CJ, LaMontagne KR, Jr, Garcia-Cardena, G, Ackley, BD, Kalman, D, Park, S, Christofferson, R, Kamihara, J, Ding, YH, Lo, KM, Gillies, S, Folkman, J, Mulligan, RC, Javaherian, K, Kuo, CJ, LaMontagne KR, Jr, Garcia-Cardena, G, Ackley, BD, Kalman, D, Park, S, Christofferson, R, Kamihara, J, Ding, YH, Lo, KM, Gillies, S, Folkman, J, Mulligan, RC, and Javaherian, K
- Published
- 2001
6. Heterogeneity of the angiogenic response induced in different normal adulttissues by vascular permeability factor/vascular endothelial growthfactor.
- Author
-
Pettersson, A, Nagy, JA, Brown, LF, Sundberg, C, Morgan, E, Jungles, S, Carter, R, Krieger, JE, Manseau, EJ, Harvey, VS, Eckelhoefer, IA, Feng, D, Dvorak, AM, Mulligan, RC, Dvorak, HF, Pettersson, A, Nagy, JA, Brown, LF, Sundberg, C, Morgan, E, Jungles, S, Carter, R, Krieger, JE, Manseau, EJ, Harvey, VS, Eckelhoefer, IA, Feng, D, Dvorak, AM, Mulligan, RC, and Dvorak, HF
- Published
- 2000
7. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
- Author
-
Rodino-Klapac LR, Lee J, Mulligan RC, Clark KR, and Mendell JR
- Published
- 2008
- Full Text
- View/download PDF
8. Handing Off the Older Patient: Improved Documentation of Geriatric Assessment in Transitions of Care.
- Author
-
Blomberg BA, Mulligan RC, Staub SJ, Hanson LC, Drickamer MA, and Dale MC
- Subjects
- Advance Care Planning, Aged, 80 and over, Cognition, Electronic Health Records, Female, Hospitalization, Humans, Male, Documentation standards, Geriatric Assessment, Internship and Residency organization & administration, Patient Transfer methods, Quality Improvement
- Abstract
Objectives: To improve assessment and documentation of function, cognition, and advance care planning (ACP) in admission and discharge notes on an Acute Care of the Elderly (ACE) unit., Design: Continuous quality improvement intervention with episodic data review., Setting: ACE unit of an 866-bed academic tertiary hospital., Participants: Housestaff physicians rotating on the ACE unit (N = 31)., Intervention: Introduction of templated notes, housestaff education, leadership outreach, and posted reminders., Measurements: Documentation of function, cognition, and ACP were assessed through chart review of a weekly sample of the ACE unit census and scored using predefined criteria., Results: Medical records (N = 172) were reviewed. At baseline, 0% of admission and discharge notes met minimum documentation criteria for all 3 domains (function, cognition, ACP). Documentation of function and cognition was completely absent at baseline. After the intervention, there was marked improvement in all measures, with 64% of admission notes and 94% of discharge notes meeting minimum documentation criteria or better in all 3 domains., Conclusion: A quality improvement intervention using geriatric-specific note templates, housestaff training, and reminders increased documentation of function, cognition and ACP for postacute care., (© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.)
- Published
- 2018
- Full Text
- View/download PDF
9. Familial influences on the full range of variability in attention and activity levels during adolescence: A longitudinal twin study.
- Author
-
Peng CZ, Grant JD, Heath AC, Reiersen AM, Mulligan RC, and Anokhin AP
- Subjects
- Adolescent, Attention Deficit Disorder with Hyperactivity genetics, Diseases in Twins genetics, Female, Humans, Individuality, Longitudinal Studies, Male, Phenotype, Twins genetics, Attention physiology, Attention Deficit Disorder with Hyperactivity psychology, Diseases in Twins psychology, Family psychology, Social Environment, Twins psychology
- Abstract
To investigate familial influences on the full range of variability in attention and activity across adolescence, we collected maternal ratings of 339 twin pairs at ages 12, 14, and 16, and estimated the transmitted and new familial influences on attention and activity as measured by the Strengths and Weaknesses of Attention-Deficit/Hyperactivity Disorder Symptoms and Normal Behavior Scale. Familial influences were substantial for both traits across adolescence: genetic influences accounted for 54%-73% (attention) and 31%-73% (activity) of the total variance, and shared environmental influences accounted for 0%-22% of the attention variance and 13%-57% of the activity variance. The longitudinal stability of individual differences in attention and activity was largely accounted for by familial influences transmitted from previous ages. Innovations over adolescence were also partially attributable to familial influences. Studying the full range of variability in attention and activity may facilitate our understanding of attention-deficit/hyperactivity disorder's etiology and intervention.
- Published
- 2016
- Full Text
- View/download PDF
10. The genetics of impulsivity: evidence for the heritability of delay discounting.
- Author
-
Anokhin AP, Grant JD, Mulligan RC, and Heath AC
- Subjects
- Adolescent, Female, Humans, Male, Phenotype, Reward, Delay Discounting physiology, Impulsive Behavior physiology
- Abstract
Background: Delay discounting (DD), a decline in the subjective value of reward with increasing delay until its receipt, is an established behavioral model of impulsive choice, a key component of a broader impulsivity construct. Greater DD, i.e., a tendency to choose smaller immediate over larger delayed rewards, has been implicated as a potential intermediate phenotype (endophenotype) for addictive disorders and comorbid externalizing psychopathology, particularly in adolescence. However, genetic and environmental origins of DD remain unclear. Accordingly, the goal of the present study was to assess heritability of DD, an important aspect of its utility as an endophenotype., Methods: A commonly used computerized procedure involving choice between varying amounts of money available immediately and a standard amount of $100 presented at variable delays was administered to a population-based sample of twins aged 16 and 18 (n = 560, including 134 monozygotic and 142 dizygotic pairs). DD was quantified using area under the discounting curve and the k coefficient estimated by fitting a hyperbolic model to individual data. Heritability was assessed using linear structural equation modeling of twin data., Results: The genetic analysis revealed significant heritability of both DD measures (area under the discounting curve: 46% and 62%; k: 35% and 55% at age 16 and 18, respectively)., Conclusions: The present study provides evidence for heritability of both model-based and model-free DD measures and suggests that DD is a promising intermediate phenotype for genetic dissection of impulsivity and externalizing spectrum disorders., (Copyright © 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
11. Long-term test-retest reliability of delayed reward discounting in adolescents.
- Author
-
Anokhin AP, Golosheykin S, and Mulligan RC
- Subjects
- Adolescent, Aging psychology, Cohort Studies, Conditioning, Operant physiology, Decision Making, Female, Humans, Impulsive Behavior, Longitudinal Studies, Male, Psychology, Adolescent, Reproducibility of Results, Delay Discounting physiology, Reward
- Abstract
Delay discounting (DD), a decline in subjective value of a reward with increasing temporal delay in receipt of that reward, is an established behavioral indicator of impulsivity. Preference for smaller-immediate over larger-delayed rewards has been implicated in the basic neurobehavioral mechanisms of risk for addictive disorders and related externalizing psychopathology. Establishing long-term stability of DD in adolescence is a necessary step towards its validation as an intermediate phenotype, or marker of risk, in neurobiological and genetic studies. Previous studies have demonstrated moderate to high test-retest reliability of DD, however, these studies utilized adult samples and examined relatively short retest intervals. Due to continuing development of brain and behavior, stability of temporal discounting behavior in adolescence may differ from that in adulthood. Here, two cohorts of adolescents aged 16 (n=126) and 18 (n=111) were administered a computerized test of DD and re-tested two years later. DD rate showed a modest but significant decrease with age, suggesting a reduction in overall impulsivity from middle to late adolescence. Significant test-retest correlations were observed in both cohorts (.67 and .76, respectively, p<.001) indicating longitudinal stability of individual differences in decision-making behavior during middle and late adolescence. This article is part of a Special Issue entitled: insert SI title., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
12. Development of gene transfer technology.
- Author
-
Mulligan RC
- Subjects
- Humans, Gene Transfer Techniques trends, Genetic Therapy methods, Genetic Vectors
- Published
- 2014
- Full Text
- View/download PDF
13. Neural correlates of inhibitory control and functional genetic variation in the dopamine D4 receptor gene.
- Author
-
Mulligan RC, Kristjansson SD, Reiersen AM, Parra AS, and Anokhin AP
- Subjects
- Adolescent, Brain blood supply, Choice Behavior physiology, Female, Genetic Association Studies, Genotype, Humans, Imaging, Three-Dimensional, Longitudinal Studies, Magnetic Resonance Imaging, Male, Oxygen blood, Social Control, Informal, Young Adult, Brain physiology, Brain Mapping, Executive Function physiology, Inhibition, Psychological, Minisatellite Repeats genetics, Receptors, Dopamine D4 genetics
- Abstract
Background: The dopamine D4 receptor gene (DRD4) has been implicated in psychiatric disorders in which deficits of self-regulation are a prominent feature (e.g., attention-deficit hyperactivity disorder and substance use disorders) and in dopamine D4 receptor insensitivity within prefrontal regions of the brain. Our hypothesis was that carriers of 7-repeats in the Variable Number of Tandem Repeats (VNTR) of DRD4 (7R+) would recruit prefrontal brain regions involved in successful inhibitory control to a lesser degree than non-carriers (7R-) and demonstrate less inhibitory control as confirmed by observation of locally reduced blood oxygenation level dependent (BOLD) % signal change and lower accuracy while performing "No-Go" trials of a Go/No-Go task., Methods: Participants (age=18, n=62, 33 females) were recruited from the general population of the St. Louis, Missouri region. Participants provided a blood or saliva sample for genotyping, completed drug and alcohol-related questionnaires and IQ testing, and performed a Go/No-Go task inside of a 3T fMRI scanner., Results: Go/No-Go task performance did not significantly differ between 7R+ and 7R- groups. Contrast of brain activity during correct "No-Go" trials with a non-target letter baseline revealed significant BOLD activation in a network of brain regions previously implicated in inhibitory control including bilateral dorsolateral prefrontal, inferior frontal, middle frontal, medial prefrontal, subcortical, parietal/temporal, and occipital/cerebellar brain regions. Mean BOLD % signal change during "No-Go" trials was significantly modulated by DRD4 genotype, with 7R+ showing a lower hemodynamic response than 7R- in right anterior prefrontal cortex/inferior frontal gyrus, left premotor cortex, and right occipital/cerebellar areas. Follow-up analyses suggested that 7-repeat status accounted for approximately 5-6% of the variance in the BOLD response during "No-Go" trials., Discussion: The DRD4 7-repeat allele may alter dopaminergic function in brain regions involved in inhibitory control. When individuals must inhibit a prepotent motor response, presence of this allele may account for 5-6% of the variance in BOLD signal in brain regions critically associated with inhibitory control, but its influence may be associated with a greater effect on brain than on behavior in 18-year-olds from the general population., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
14. Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.
- Author
-
Xu X, Clark US, David SP, Mulligan RC, Knopik VS, McGeary J, MacKillop J, McCaffery J, Niaura RS, and Sweet LH
- Subjects
- Adult, Alleles, Amygdala drug effects, Brain drug effects, Exons, Female, Genotype, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Motivation, Nicotine pharmacology, Polymorphism, Genetic, Smoking genetics, White People genetics, Cues, Minisatellite Repeats, Nicotine administration & dosage, Receptors, Dopamine D4 genetics
- Abstract
Introduction: Reactivity to smoking cues is an important factor in the motivation to smoke and has been associated with the dopamine receptor 4 variable number tandem repeat (DRD4 exon III VNTR) polymorphism. However, little is known about the associated neural mechanisms., Methods: Non-treatment-seeking Caucasian smokers completed overnight abstinence and viewed smoking and neutral cues during 2 separate functional magnetic resonance imaging scans while wearing either a nicotine or placebo patch (order randomized) and were genotyped for the DRD4 VNTR. We conducted mixed-effects repeated-measures analyses of variance (within-subject factor: nicotine or placebo patch; between-subject factor: DRD4 long [L: ≥ 1 copy of ≥ 7 repeats] or short [S: 2 copies ≤ 6 repeats] genotype) of 6 a priori regions of interest., Results: Relative to neutral cues, smoking cues elicited greater activity in bilateral ventral striatum and left amygdala during nicotine replacement and deactivation in these regions during nicotine deprivation. A patch × DRD4 interaction was observed in the left amygdala, an area associated with appetitive reinforcement and relapse risk, such that S allele carriers demonstrated greater activation on active patch than on placebo patch., Conclusions: Brain systems associated with reward salience may become primed and overreactive at nicotine replacement doses intended for the first step of smoking cessation and may become inhibited during nicotine withdrawal in DRD4 S but not in DRD4 L carriers. These findings are consistent with the role of these regions in drug reinforcement and suggest a differential influence of nicotine replacement on amygdala activation in the association of incentive salience with smoking stimuli across DRD4 genotypes., (© The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
15. Attention-Deficit/Hyperactivity Disorder, Autistic Traits, and Substance Use Among Missouri Adolescents.
- Author
-
Mulligan RC, Reiersen AM, and Todorov AA
- Abstract
Background: Although existing literature demonstrates the association of attention-deficit/hyperactivity disorder (ADHD) with both substance use (SU) and autism spectrum disorder (ASD), few studies have examined rates of SU among adolescents with elevated ASD symptoms, with or without comorbid ADHD. Clinic-based studies suggest a possible protective effect of ASD against SU, but this has not been confirmed in population-based studies., Objective: We examined alcohol, tobacco, and drug use in adolescents with either ADHD, elevated autistic traits, or both as compared with controls., Methods: Subjects (N = 2937) who were 13 to 17 years old from a Missouri population-based large sibship sample were assessed for ADHD, autistic traits, and SU with the use of parent-report questionnaires. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition ADHD symptom criterion (Criterion A) was applied to the Strengths and Weaknesses of ADHD-symptoms and Normal-behavior (SWAN) questionnaire item responses to determine ADHD diagnosis. The presence of elevated autistic traits was defined as a raw Social Responsiveness Scale (SRS) score of 62 (95
th percentile for this sample) or higher. SU was determined with the use of three items from the Child Behavior Checklist (CBCL). Statistical methods used included logistic and fractional polynomial regression., Results: As compared with controls, adolescents with ADHD were at increased risk for alcohol, tobacco, and drug use whether or not they had elevated autistic traits. Adolescents with elevated autistic traits were at significantly increased risk for drug use other than alcohol and tobacco, even if they did not have ADHD. Among those with raw SRS scores in the range of about 20 (normal) to 80 (consistent with mild to moderate ASD), adolescents with ADHD had higher levels of SU than control individuals with similar levels of autistic traits. However, strong conclusions cannot be drawn regarding individuals with very low or very high SRS scores as a result of sparse data., Conclusions: This study confirms previous research showing an increased risk of SU among adolescents with ADHD. It also provides new information indicating that adolescents with high levels of autistic traits are at elevated risk for alcohol and tobacco use if they have comorbid ADHD; in addition, they may be at high risk for other drug use, even if they do not have comorbid ADHD. Therefore, it should not be assumed that adolescents with mild to moderate ASD have a low risk of SU, especially if ADHD is also present.- Published
- 2014
- Full Text
- View/download PDF
16. Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.
- Author
-
Burkhardt UE, Hainz U, Stevenson K, Goldstein NR, Pasek M, Naito M, Wu D, Ho VT, Alonso A, Hammond NN, Wong J, Sievers QL, Brusic A, McDonough SM, Zeng W, Perrin A, Brown JR, Canning CM, Koreth J, Cutler C, Armand P, Neuberg D, Lee JS, Antin JH, Mulligan RC, Sasada T, Ritz J, Soiffer RJ, Dranoff G, Alyea EP, and Wu CJ
- Subjects
- Adult, Aged, Combined Modality Therapy, Disease-Free Survival, Female, Granulocyte-Macrophage Colony-Stimulating Factor metabolism, Humans, K562 Cells, Leukemia, Lymphocytic, Chronic, B-Cell immunology, Leukemia, Lymphocytic, Chronic, B-Cell mortality, Male, Middle Aged, Prospective Studies, Transplantation Conditioning, Transplantation, Autologous, Treatment Outcome, Vaccination, CD8-Positive T-Lymphocytes immunology, Cancer Vaccines, Hematopoietic Stem Cell Transplantation, Leukemia, Lymphocytic, Chronic, B-Cell therapy
- Abstract
Background: Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whether vaccination with whole leukemia cells early after transplantation facilitates the expansion of leukemia-reactive T cells and thereby enhances antitumor immunity., Methods: We enrolled 22 patients with advanced chronic lymphocytic leukemia (CLL), 18 of whom received up to 6 vaccines initiated between days 30 and 45 after transplantation. Each vaccine consisted of irradiated autologous tumor cells admixed with GM-CSF-secreting bystander cells. Serial patient PBMC samples following transplantation were collected, and the impact of vaccination on T cell activity was evaluated., Results: At a median follow-up of 2.9 (range, 1-4) years, the estimated 2-year progression-free and overall survival rates of vaccinated subjects were 82% (95% CI, 54%-94%) and 88% (95% CI, 59%-97%), respectively. Although vaccination only had a modest impact on recovering T cell numbers, CD8+ T cells from vaccinated patients consistently reacted against autologous tumor, but not alloantigen-bearing recipient cells with increased secretion of the effector cytokine IFN-γ, unlike T cells from nonvaccinated CLL patients undergoing allo-HSCT. Further analysis confirmed that 17% (range, 13%-33%) of CD8+ T cell clones isolated from 4 vaccinated patients by limiting dilution of bulk tumor-reactive T cells solely reacted against CLL-associated antigens., Conclusion: Our studies suggest that autologous tumor cell vaccination is an effective strategy to advance long-term leukemia control following allo-HSCT., Trial Registration: Clinicaltrials.gov NCT00442130., Funding: NCI (5R21CA115043-2), NHLBI (5R01HL103532-03), and Leukemia and Lymphoma Society Translational Research Program.
- Published
- 2013
- Full Text
- View/download PDF
17. Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients.
- Author
-
Brusic A, Hainz U, Wadleigh M, Neuberg D, Su M, Canning CM, Deangelo DJ, Stone RM, Lee JS, Mulligan RC, Ritz J, Dranoff G, Sasada T, and Wu CJ
- Abstract
BCR-ABL(+) K562 cells hold clinical promise as a component of cancer vaccines, either as bystander cells genetically modified to express immunostimulatory molecules, or as a source of leukemia antigens. To develop a method for detecting T-cell reactivity against K562 cell-derived antigens in patients, we exploited the dendritic cell (DC)-mediated cross-presentation of proteins generated from apoptotic cells. We used UVB irradiation to consistently induce apoptosis of K562 cells, which were then fed to autologous DCs. These DCs were used to both stimulate and detect antigen-specific CD8(+) T-cell reactivity. As proof-of-concept, we used cross-presented apoptotic influenza matrix protein-expressing K562 cells to elicit reactivity from matrix protein-reactive T cells. Likewise, we used this assay to detect increased anti-CML antigen T-cell reactivity in CML patients that attained long-lasting clinical remissions following immunotherapy (donor lymphocyte infusion), as well as in 2 of 3 CML patients vaccinated with lethally irradiated K562 cells that were modified to secrete high levels of granulocyte macrophage colony-stimulating factor (GM-CSF). This methodology can be readily adapted to examine the effects of other whole tumor cell-based vaccines, a scenario in which the precise tumor antigens that stimulate immune responses are unknown.
- Published
- 2012
- Full Text
- View/download PDF
18. Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.
- Author
-
Clark US, Cohen RA, Sweet LH, Gongvatana A, Devlin KN, Hana GN, Westbrook ML, Mulligan RC, Jerskey BA, White TL, Navia B, and Tashima KT
- Subjects
- Adult, Brain pathology, CD4 Lymphocyte Count, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Psychomotor Performance physiology, Surveys and Questionnaires, Wechsler Scales, Amygdala pathology, Cognition physiology, HIV Infections pathology, HIV Infections psychology, Stress, Psychological psychology
- Abstract
Both HIV infection and high levels of early life stress (ELS) have been related to abnormalities in frontal-subcortical structures, yet the combined effects of HIV and ELS on brain structure and function have not been previously investigated. In this study we assessed 49 non-demented HIV-seropositive (HIV+) and 47 age-matched HIV-seronegative healthy control (HC) adults. Levels of ELS exposure were quantified and used to define four HIV-ELS groups: HC Low-ELS (N = 20); HC High-ELS (N = 27); HIV+ Low-ELS (N = 24); HIV+ High-ELS (N = 25). An automated segmentation tool measured volumes of brain structures known to show HIV-related or ELS-related effects; a brief neurocognitive battery was administered. A significant HIV-ELS interaction was observed for amygdala volumes, which was driven by enlargements in HIV+ High-ELS participants. The HIV+ High-ELS group also demonstrated significant reductions in psychomotor/processing speed compared with HC Low-ELS. Regression analyses in the HIV+ group revealed that amygdala enlargements were associated with higher ELS, lower nadir CD4 counts, and reduced psychomotor/processing speed. Our results suggest that HIV infection and high ELS interact to increase amygdala volume, which is associated with neurocognitive dysfunction in HIV+ patients. These findings highlight the lasting neuropathological influence of ELS and suggest that high ELS may be a significant risk factor for neurocognitive impairment in HIV-infected individuals.
- Published
- 2012
- Full Text
- View/download PDF
19. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
- Author
-
Herson S, Hentati F, Rigolet A, Behin A, Romero NB, Leturcq F, Laforêt P, Maisonobe T, Amouri R, Haddad H, Audit M, Montus M, Masurier C, Gjata B, Georger C, Cheraï M, Carlier P, Hogrel JY, Herson A, Allenbach Y, Lemoine FM, Klatzmann D, Sweeney HL, Mulligan RC, Eymard B, Caizergues D, Voït T, and Benveniste O
- Subjects
- Adolescent, Adult, Dependovirus genetics, Dependovirus metabolism, Female, Follow-Up Studies, Genetic Vectors, Humans, Male, Muscular Dystrophies, Limb-Girdle genetics, Muscular Dystrophies, Limb-Girdle metabolism, Sarcoglycans metabolism, Treatment Outcome, Gene Transfer Techniques, Genetic Therapy methods, Muscular Dystrophies, Limb-Girdle therapy, Sarcoglycans genetics
- Abstract
γ-Sarcoglycanopathy or limb girdle muscular dystrophy type 2C is an untreatable disease caused by autosomal recessively inherited mutations of the γ-sarcoglycan gene. Nine non-ambulatory patients (two males, seven females, mean age 27 years; range 16-38 years) with del525T homozygous mutation of the γ-sarcoglycan gene and no γ-sarcoglycan immunostaining on muscle biopsy were divided into three equal groups to receive three escalating doses of an adeno-associated virus serotype 1 vector expressing the human γ-sarcoglycan gene under the control of the desmin promoter, by local injection into the extensor carpi radialis muscle. The first group received a single injection of 3 × 10(9) viral genomes in 100 µl, the second group received a single injection of 1.5 × 10(10) viral genomes in 100 µl, and the third group received three simultaneous 100-µl injections at the same site, delivering a total dose of 4.5 × 10(10) viral genomes. No serious adverse effects occurred during 6 months of follow-up. All nine patients became adeno-associated virus serotype 1 seropositive and one developed a cytotoxic response to the adeno-associated virus serotype 1 capsid. Thirty days later, immunohistochemical analysis of injected-muscle biopsy specimens showed γ-sarcoglycan expression in all three patients who received the highest dose (4.7-10.5% positively stained fibres), while real-time polymerase chain reaction detected γ-sarcoglycan messenger RNA. In one patient, γ-sarcoglycan protein was detected by western blot. For two other patients who received the low and intermediate doses, discrete levels of γ-sarcoglycan expression (<1% positively stained fibres) were also detectable. Expression of γ-sarcoglycan protein can be induced in patients with limb girdle muscular dystrophy type 2C by adeno-associated virus serotype 1 gene transfer, with no serious adverse effects.
- Published
- 2012
- Full Text
- View/download PDF
20. Neural correlates of inhibitory control in adult attention deficit/hyperactivity disorder: evidence from the Milwaukee longitudinal sample.
- Author
-
Mulligan RC, Knopik VS, Sweet LH, Fischer M, Seidenberg M, and Rao SM
- Subjects
- Adult, Attention Deficit Disorder with Hyperactivity psychology, Brain blood supply, Decision Making physiology, Female, Humans, Image Processing, Computer-Assisted, Intelligence, Longitudinal Studies, Magnetic Resonance Imaging methods, Male, Neuropsychological Tests, Oxygen blood, Wisconsin epidemiology, Attention Deficit Disorder with Hyperactivity complications, Brain physiopathology, Brain Mapping, Cognition Disorders etiology, Cognition Disorders pathology, Inhibition, Psychological
- Abstract
Only a few studies have investigated the neural substrate of response inhibition in adult attention deficit hyperactivity disorder (ADHD) using Stop-Signal and Go/No-Go tasks. Inconsistencies and methodological limitations in the existing literature have resulted in limited conclusions regarding underlying pathophysiology. We examined the neural basis of response inhibition in a group of adults diagnosed with ADHD in childhood and who continue to meet criteria for ADHD. Adults with ADHD (n=12) and controls (n=12) were recruited from an ongoing longitudinal study and were matched for age, IQ, and education. Individuals with comorbid conditions were excluded. Functional magnetic resonance imaging (fMRI) was used to identify and compare the brain activation patterns during correct trials of a response-inhibition task (Go/No-Go). Our results showed that the control group recruited a more extensive network of brain regions than the ADHD group during correct inhibition trials. Adults with ADHD showed reduced brain activation in the right frontal eye field, pre-supplementary motor area, left precentral gyrus, and the inferior parietal lobe bilaterally. During successful inhibition of an inappropriate response, adults with ADHD display reduced activation in fronto-parietal networks previously implicated in working memory, goal-oriented attention, and response selection. This profile of brain activation may be specifically associated with ADHD in adulthood., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
21. Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation.
- Author
-
Sanchez CE, Tierney TS, Gale JT, Alavian KN, Sahin A, Lee JS, Mulligan RC, and Carter BS
- Subjects
- Animals, Caspase 3 metabolism, Genetic Vectors, Green Fluorescent Proteins, Humans, Immunohistochemistry, Macaca mulatta, Magnetic Resonance Imaging, Neostriatum cytology, Safety, Stereotaxic Techniques, Dependovirus genetics, Gene Transfer Techniques adverse effects, Neostriatum physiology, Transduction, Genetic
- Abstract
Object: Although several clinical trials utilizing the adeno-associated virus (AAV) type 2 serotype 2 (2/2) are now underway, it is unclear whether this particular serotype offers any advantage over others in terms of safety or efficiency when delivered directly to the CNS., Methods: Recombinant AAV2-green fluorescent protein (GFP) serotypes 2/1, 2/2, 2/5, and 2/8 were generated following standard triple transfection protocols (final yield 5.4 × 10(12) particles/ml). A total of 180 μl of each solution was stereotactically infused, covering the entire rostrocaudal extent of the caudoputamen in 4 rhesus monkeys (Macaca mulatta) (3.0 ± 0.5 kg). After 6 weeks' survival, the brain was formalin fixed, cut at 40 μm, and stained with standard immunohistochemistry for anti-GFP, anticaspase-2, and cell-specific markers (anti-microtubule-associated protein-2 for neurons and anti-glial fibrillary acidic protein for glia). Unbiased stereological counting methods were used to determine cell number and striatal volume., Results: The entire striatum of each animal contained GFP-positive cells with significant labeling extending beyond the borders of the basal ganglia. No ischemic/necrotic, hemorrhagic, or neoplastic change was observed in any brain. Total infusate volumes were similar across the 4 serotypes. However, GFP-labeled cell density was markedly different. Adeno-associated virus 2/1, 2/2, and 2/5 each labeled < 8000 cells/mm(3), whereas serotype 8 labeled > 21,000 cells, a 3- to 4-fold higher transduction efficiency. On the other hand, serotype 8 also labeled neurons and glia with equal affinity compared with neuronal specificities > 89% for the other serotypes. Moderate caspase-2 colabeling was noted in neurons immediately around the AAV2/1 injection tracts, but was not seen above the background anywhere in the brain following injections with serotypes 2, 5, or 8., Conclusions: Intrastriatal delivery of AAV2 yields the highest cell transduction efficiencies but lowest neuronal specificity for serotype 8 when compared with serotypes 1, 2, and 5. Only AAV2/1 revealed significant caspase-2 activation. Careful consideration of serotype-specific differences in AAV2 neurotropism, transduction efficiency, and potential toxicity may affect future human trials.
- Published
- 2011
- Full Text
- View/download PDF
22. Effects of nicotine withdrawal on verbal working memory and associated brain response.
- Author
-
Sweet LH, Mulligan RC, Finnerty CE, Jerskey BA, David SP, Cohen RA, and Niaura RS
- Subjects
- Adult, Affect physiology, Brain blood supply, Brain drug effects, Female, Humans, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging methods, Male, Memory, Short-Term drug effects, Middle Aged, Neuropsychological Tests, Substance Withdrawal Syndrome physiopathology, Substance Withdrawal Syndrome psychology, Verbal Learning drug effects, Brain pathology, Memory, Short-Term physiology, Nicotine adverse effects, Nicotinic Agonists adverse effects, Substance Withdrawal Syndrome pathology, Verbal Learning physiology
- Abstract
Previous literature has reported effects of nicotine withdrawal on brain function during cognitive tasks such as verbal working memory (VWM). Mechanisms of these withdrawal effects have not been clearly identified. Functional neuroimaging offers an objective method to examine brain mechanisms associated with observable behavior and subjective reports. To investigate these mechanisms, 12 smokers were administered a 2-Back VWM challenge during two functional magnetic resonance imaging sessions. Participants abstained from smoking prior to both sessions; however, they applied a nicotine patch before one session and a placebo patch prior to the other. Among regions that exhibited a significant response to the 2-Back during either session, withdrawal was associated with significantly greater deactivation in left and right temporal poles and left medial frontal gyrus. The magnitude of task-related activation showed a significant inverse relationship to craving in the majority of regions during placebo administration. Also, individual brain responses varied more during placebo, suggesting inefficient neural processing. Results suggest that differences in brain response to a VWM challenge during abstinence may be attributed to increased craving. Further deactivation of regions associated with the default network (medial frontal and anterior temporal clusters) during the placebo condition suggests further suspension of default activity, possibly to compensate for inefficient neural processing., (Copyright 2010 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
23. Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.
- Author
-
Wilson AA, Murphy GJ, Hamakawa H, Kwok LW, Srinivasan S, Hovav AH, Mulligan RC, Amar S, Suki B, and Kotton DN
- Subjects
- Animals, Humans, Inflammation etiology, Leukocyte Common Antigens analysis, Membrane Glycoproteins genetics, Mice, Mice, Inbred C57BL, Transduction, Genetic, Viral Envelope Proteins genetics, Emphysema therapy, Genetic Therapy, Lentivirus genetics, Macrophages, Alveolar metabolism, alpha 1-Antitrypsin genetics
- Abstract
Directed gene transfer into specific cell lineages in vivo is an attractive approach for both modulating gene expression and correcting inherited mutations such as emphysema caused by human alpha1 antitrypsin (hAAT) deficiency. However, somatic tissues are mainly comprised of heterogeneous, differentiated cell lineages that can be short lived and difficult to specifically transfect. Here, we describe an intratracheally instilled lentiviral system able to deliver genes selectively to as many as 70% of alveolar macrophages (AMs) in the mouse lung. Following a single in vivo lentiviral transduction, genetically tagged AMs persisted in lung alveoli and expressed transferred genes for the lifetime of the adult mouse. A prolonged macrophage lifespan, rather than precursor cell proliferation, accounted for the surprisingly sustained presence of transduced AMs. We utilized this long-lived population to achieve localized secretion of therapeutic levels of hAAT protein in lung epithelial lining fluid. In an established mouse model of emphysema, lentivirally delivered hAAT ameliorated the progression of emphysema, as evidenced by attenuation of increased lung compliance and alveolar size. After 24 weeks of sustained gene expression, no humoral or cellular immune responses to hAAT protein were detected. Our results challenge the dogma that AMs are short lived and suggest that these differentiated cells may be a possible target cell population for in vivo gene therapy applications, including the sustained correction of hAAT deficiency.
- Published
- 2010
- Full Text
- View/download PDF
24. A fMRI Study of Verbal Working Memory, Cardiac Output, and Ejection Fraction in Elderly Patients with Cardiovascular Disease.
- Author
-
Irani F, Sweet LH, Haley AP, Gunstad JJ, Jerskey BA, Mulligan RC, Jefferson AL, Poppas A, and Cohen RA
- Abstract
Cardiovascular disease (CVD) is associated with cognitive deficits even in the absence of stroke. We examined the relationship between cardiac performance, as measured by cardiac output (CO) and ejection fraction (EF), and brain activity during a verbal working memory (VWM) task in elderly CVD patients who tend to be at increased risk for vascular cognitive impairments. Seventeen patients were recruited from a cohort participating in an ongoing prospective study examining the effects of CVD on cognitive function in the elderly. Participants were diagnosed with CVD (age 68±8) and completed a 2-back VWM task in a 1.5T fMRI paradigm. CO and EF were calculated from echocardiogram measures. Task-related activation was averaged in a priori regions of interest. The relationship between CO, EF, and 2-back-related activity was modeled using partial correlations (two-tailed p<.05) controlling for age and 2-back accuracy. All participants were globally cognitively intact as indicated by Mini-Mental Status Exam and Dementia Rating Scale scores. Mean accuracy on the 2-back was 78±9% while reaction time averaged 1,027±192 ms. Mean CO and EF values showed a large range (CO: 3.55 to 6.31; EF: 0.36 to 0.76) but average values were within the normal range. After controlling for age and 2-back accuracy, lower EF was related to decrease in left insula activity (r=0.61, p=0.03). There were trends for EF to be related to accuracy (r=0.47, p=0.09) and reaction time (r=-0.48, p=0.09). CO was also related to insula activity (r=0.60, p=0.04) and activity in the supplementary motor area activity (r=0.66, p=0.01). Cardiac performance was related to decreased efficiency in task related brain areas and tended to be related to performance on a VWM task in elderly patients with CVD. Results have implications for a line of investigation indicating that cardiac and systemic vascular indices could be used as proxy measures to examine mechanisms of cerebrovascular dysfunction in the elderly.
- Published
- 2009
- Full Text
- View/download PDF
25. Genetically engineered T cells to target EGFRvIII expressing glioblastoma.
- Author
-
Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, and Carter BS
- Subjects
- Analysis of Variance, Cancer Vaccines genetics, Cell Line, Tumor, Cells, Cultured, Cytokines metabolism, Cytotoxicity, Immunologic genetics, Flow Cytometry methods, Gene Expression genetics, Green Fluorescent Proteins genetics, Humans, Leukocytes, Mononuclear, Transfection, ErbB Receptors genetics, ErbB Receptors metabolism, Glioblastoma genetics, Glioblastoma immunology, T-Lymphocytes immunology
- Abstract
Glioblastoma remains a significant therapeutic challenge, warranting further investigation of novel therapies. We describe an immunotherapeutic strategy to treat glioblastoma based on adoptive transfer of genetically modified T-lymphocytes (T cells) redirected to kill EGFRvIII expressing gliomas. We constructed a chimeric immune receptor (CIR) specific to EGFRvIII, (MR1-zeta). After in vitro selection and expansion, MR1-zeta genetically modified primary human T-cells specifically recognized EGFRvIII-positive tumor cells as demonstrated by IFN-gamma secretion and efficient tumor lysis compared to control CIRs defective in EGFRvIII binding (MRB-zeta) or signaling (MR1-delzeta). MR1-zeta expressing T cells also inhibited EGFRvIII-positive tumor growth in vivo in a xenografted mouse model. Successful targeting of EGFRvIII-positive tumors via adoptive transfer of genetically modified T cells may represent a new immunotherapy strategy with great potential for clinical applications.
- Published
- 2009
- Full Text
- View/download PDF
26. A mammalian cell-based assay for screening inhibitors of RNA cleavage.
- Author
-
Yen L, Stockwell BR, and Mulligan RC
- Subjects
- Cell Line, Clone Cells, Genes, Reporter, Humans, Oligonucleotides, Antisense pharmacology, Reproducibility of Results, Biological Assay methods, RNA metabolism, RNA Processing, Post-Transcriptional drug effects, Small Molecule Libraries analysis, Small Molecule Libraries pharmacology
- Abstract
RNA cleavage is a catalytic reaction which defines many types of RNA processing events, including those of metabolite-sensing riboswitch, self-splicing introns, mRNA splicing, tRNA processing, polyA-cleavage, and various small ribozymes such as hairpin and hammerhead ribozyme. In this chapter, we describe a general methodology for developing a mammalian cell-based high-throughput screening assay useful for identifying small molecules capable of inhibiting RNA cleavage in mammalian cells. In the specific assay described, a plasmid DNA vector in which the expression of a luciferase reporter gene is controlled by hammerhead ribozyme cleavage was stably introduced into the human 293 cell line. Such a cell line enabled the rapid screening of chemical compound libraries and the identification of cell membrane-permeable inhibitory molecules capable of blocking ribozyme cleavage. The general strategy described later could in principle be adapted to identify small molecule inhibitors of many types of RNA cleavage reactions.
- Published
- 2009
- Full Text
- View/download PDF
27. Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.
- Author
-
Kuhnert F, Tam BY, Sennino B, Gray JT, Yuan J, Jocson A, Nayak NR, Mulligan RC, McDonald DM, and Kuo CJ
- Subjects
- Adenoviridae genetics, Animals, Corpus Luteum blood supply, Corpus Luteum cytology, Female, Genetic Therapy, Hemorrhage etiology, Mice, Mice, Inbred C57BL, Neoplasms, Experimental blood supply, Neoplasms, Experimental genetics, Neoplasms, Experimental therapy, Pericytes cytology, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Neoplasm genetics, RNA, Neoplasm metabolism, Receptor, Platelet-Derived Growth Factor beta physiology, Recombinant Proteins genetics, Recombinant Proteins metabolism, Signal Transduction, Solubility, Vascular Endothelial Growth Factor Receptor-2 genetics, Vascular Endothelial Growth Factor Receptor-2 physiology, Neovascularization, Pathologic, Neovascularization, Physiologic, Receptor, Platelet-Derived Growth Factor beta antagonists & inhibitors, Vascular Endothelial Growth Factor Receptor-2 antagonists & inhibitors
- Abstract
The simultaneous targeting of both endothelial cells and pericytes via inhibition of VEGF receptor (VEGFR) and PDGFbeta receptor (PDGFRbeta) signaling, respectively, has been proposed to enhance the efficacy of antiangiogenic tumor therapy. Clinical and preclinical modeling of combined VEGFR and PDGFRbeta signaling inhibition, however, has used small molecule kinase inhibitors with inherently broad substrate specificities, precluding detailed examination of this hypothesis. Here, adenoviral expression of a soluble VEGFR2/Flk1 ectodomain (Ad Flk1-Fc) in combination with a soluble ectodomain of PDGFRbeta (Ad sPDGFRbeta) allowed highly selective inhibition of these pathways. The activity of Ad sPDGFRbeta was validated in vitro against PDGF-BB and in vivo with near-complete blockade of pericyte recruitment in the angiogenic corpus luteum, resulting in prominent hemorrhage, thus demonstrating an essential function for PDGF signaling during ovarian angiogenesis. Combination therapy with Ad PDGFRbeta and submaximal doses of Ad Flk1-Fc produced modest additive antitumor effects; however, no additivity was observed with maximal VEGF inhibition in numerous s.c. models. Notably, VEGF inhibition via Ad Flk1-Fc was sufficient to strongly suppress tumor endothelial and pericyte content as well as intratumoral PDGF-B mRNA, obscuring additive Ad sPDGFRbeta effects on pericytes or tumor volume. These studies using highly specific soluble receptors suggest that additivity between VEGFR and PDGFRbeta inhibition depends on the strength of VEGF blockade and appears minimal under conditions of maximal VEGF antagonism.
- Published
- 2008
- Full Text
- View/download PDF
28. Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.
- Author
-
Szentirmai O, Baker CH, Bullain SS, Lin N, Takahashi M, Folkman J, Mulligan RC, and Carter BS
- Subjects
- Adenoviridae, Animals, Apoptosis, Endostatins analysis, Endostatins genetics, Genetic Vectors, Humans, Immunohistochemistry, In Situ Nick-End Labeling, Male, Mice, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic drug therapy, Transplantation, Heterologous, Vascular Endothelial Growth Factor Receptor-2 analysis, Vascular Endothelial Growth Factor Receptor-2 genetics, Brain Neoplasms pathology, Endostatins administration & dosage, Glioblastoma pathology, Vascular Endothelial Growth Factor Receptor-2 administration & dosage
- Abstract
Object: Glioblastoma multiforme (GBM) is characterized by neovascularization, raising the question of whether angiogenic blockade may be a useful therapeutic strategy for this disease. It has been suggested, however, that, to be useful, angiogenic blockade must be persistent and at levels sufficient to overcome proangiogenic signals from tumor cells. In this report, the authors tested the hypothesis that sustained high concentrations of 2 different antiangiogenic proteins, delivered using a systemic gene therapy strategy, could inhibit the growth of established intracranial U87 human GBM xenografts in nude mice., Methods: Mice harboring established U87 intracranial tumors received intravenous injections of adenoviral vectors encoding either the extracellular domain of vascular endothelial growth factor receptor-2-Fc fusion protein (Ad-VEGFR2-Fc) alone, soluble endostatin (Ad-ES) alone, a combination of Ad-VEGFR2-Fc and Ad-ES, or immunoglobulin 1-Fc (Ad-Fc) as a control., Results: Three weeks after treatment, magnetic resonance imaging-based determination of tumor volume showed that treatment with Ad-VEGFR2-Fc, Ad-ES, or Ad-VEGFR2-Fc in combination with Ad-ES, produced 69, 59, and 74% growth inhibition, respectively. Bioluminescent monitoring of tumor growth revealed growth inhibition in the same treatment groups to be 62, 74, and 72%, respectively. Staining with proliferating cell nuclear antigen and with terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling showed reduced tumor cell proliferation and increased apoptosis in all antiangiogenic treatment groups., Conclusions: These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis. This work adds further support to the concept of using antiangiogenesis therapy for intracranial GBM.
- Published
- 2008
- Full Text
- View/download PDF
29. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.
- Author
-
Austin KM, Gupta ML Jr, Coats SA, Tulpule A, Mostoslavsky G, Balazs AB, Mulligan RC, Daley G, Pellman D, and Shimamura A
- Subjects
- Bone Marrow Diseases metabolism, Cell Line, Humans, Microtubules metabolism, Protein Binding, Proteins genetics, Proteins metabolism, RNA, Small Interfering genetics, Syndrome, Bone Marrow Diseases genetics, Bone Marrow Diseases pathology, Genomic Instability genetics, Spindle Apparatus metabolism
- Abstract
Deficiencies in the SBDS gene result in Shwachman-Diamond syndrome (SDS), an inherited bone marrow failure syndrome associated with leukemia predisposition. SBDS encodes a highly conserved protein previously implicated in ribosome biogenesis. Using human primary bone marrow stromal cells (BMSCs), lymphoblasts, and skin fibroblasts, we show that SBDS stabilized the mitotic spindle to prevent genomic instability. SBDS colocalized with the mitotic spindle in control primary BMSCs, lymphoblasts, and skin fibroblasts and bound to purified microtubules. Recombinant SBDS protein stabilized microtubules in vitro. We observed that primary BMSCs and lymphoblasts from SDS patients exhibited an increased incidence of abnormal mitoses. Similarly, depletion of SBDS by siRNA in human skin fibroblasts resulted in increased mitotic abnormalities and aneuploidy that accumulated over time. Treatment of primary BMSCs and lymphoblasts from SDS patients with nocodazole, a microtubule destabilizing agent, led to increased mitotic arrest and apoptosis, consistent with spindle destabilization. Conversely, SDS patient cells were resistant to taxol, a microtubule stabilizing agent. These findings suggest that spindle instability in SDS contributes to bone marrow failure and leukemogenesis.
- Published
- 2008
- Full Text
- View/download PDF
30. Imaging phonological similarity effects on verbal working memory.
- Author
-
Sweet LH, Paskavitz JF, Haley AP, Gunstad JJ, Mulligan RC, Nyalakanti PK, and Cohen RA
- Subjects
- Acoustic Stimulation, Adolescent, Adult, Aged, Aged, 80 and over, Analysis of Variance, Brain anatomy & histology, Brain blood supply, Female, Humans, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging methods, Male, Middle Aged, Oxygen blood, Reaction Time physiology, Brain physiology, Brain Mapping, Memory, Short-Term physiology, Pattern Recognition, Physiological physiology, Phonetics, Verbal Behavior physiology
- Abstract
Studies of verbal working memory (VWM) report that performance declines as the phonemic similarity of stimuli increases. To determine how phonological similarity affects brain function during VWM, "standard" and "similarity" versions of the 2-Back task were presented to 34 healthy participants during functional magnetic resonance imaging (FMRI). Letter consonants presented during similarity blocks rhymed, while consonants did not rhyme during standard blocks. Empirical ROIs were identified from significant 2-Back-related activity observed during either condition. A priori ROIs were selected from functional neuroimaging literature on phonological processing. Although VWM-related activity was not modulated by similarity in any of four regions recruited (dorsolateral prefrontal, posterior parietal, anterior insular, and supplementary motor cortices), four of five regions of deactivation exhibited significantly greater deactivation during the similarity compared to the standard condition (posterior cingulate, paracentral lobule, posterior insula, and parahippocampal gyrus). In a priori phonological processing-related ROIs, similarity did not affect observed increases in activity (supplementary motor area, Broca's area, and cerebellum), while two of the three regions exhibiting decreased activity (near Wernicke's area and Heschel's Gyrus) also exhibited more deactivation during similarity. Accuracy was lower during the similarity 2-Back, positively related to activity within recruited VWM-related ROIs, and inversely related to activity in regions of VWM-related deactivation. Based on known functions of these ROIs, we conclude that language, audition, and self-reflection processes may disengage during phonological interference, while activity levels are maintained in regions recruited during VWM processing. Similarity effects likely include suspension of attention to unrelated and distracting processes to improve concentration.
- Published
- 2008
- Full Text
- View/download PDF
31. Engineering high-speed allosteric hammerhead ribozymes.
- Author
-
Link KH, Guo L, Ames TD, Yen L, Mulligan RC, and Breaker RR
- Subjects
- Allosteric Regulation, Allosteric Site, Animals, Base Sequence, Caffeine chemistry, Caffeine pharmacology, Cell Line, Clone Cells, Gene Expression Regulation drug effects, Humans, Kinetics, Molecular Sequence Data, Nucleic Acid Conformation, RNA, Catalytic chemistry, Regulatory Sequences, Ribonucleic Acid, SELEX Aptamer Technique, Sequence Analysis, RNA, Theophylline chemistry, Theophylline pharmacology, Genetic Engineering, RNA, Catalytic genetics, RNA, Catalytic metabolism, Schistosoma mansoni enzymology
- Abstract
Full-length hammerhead ribozymes were subjected to in vitro selection to identify variants that are allosterically regulated by theophylline in the presence of a physiologically relevant concentration of Mg(2+). The population of allosteric ribozymes resulting from 15 rounds of in vitro selection yielded variants with observed rate constants (k (obs)) as high as 8 min(-1) in the presence of theophylline and maximal k (obs) increases of up to 285-fold compared to rate constants measured in the absence of effector. The selected ribozymes have kinetic characteristics that are predicted to be sufficient for cellular gene control applications, but do not exhibit any activity in reporter gene assays. The inability of the engineered RNAs to control gene expression suggests that the in vitro and in vivo folding pathways of the RNAs are different. These results provide several key pieces of information that will aid in future efforts to engineer allosteric ribozymes for gene control applications.
- Published
- 2007
- Full Text
- View/download PDF
32. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
- Author
-
Butler MO, Lee JS, Ansén S, Neuberg D, Hodi FS, Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM, and Hirano N
- Subjects
- Antigen Presentation immunology, Antigen-Presenting Cells immunology, Antigens, Neoplasm metabolism, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes metabolism, Cell Proliferation drug effects, Half-Life, Humans, Interferon-gamma metabolism, Interleukin-15 pharmacology, K562 Cells, MART-1 Antigen, Melanoma immunology, Melanoma metabolism, Melanoma pathology, Neoplasm Proteins metabolism, Tumor Cells, Cultured, Antigen-Presenting Cells transplantation, Biomimetics methods, CD8-Positive T-Lymphocytes transplantation, Immunotherapy, Adoptive, Melanoma therapy
- Abstract
Purpose: Antitumor lymphocytes can be generated ex vivo unencumbered by immunoregulation found in vivo. Adoptive transfer of these cells is a promising therapeutic modality that could establish long-term antitumor immunity. However, the widespread use of adoptive therapy has been hampered by the difficulty of consistently generating potent antitumor lymphocytes in a timely manner for every patient. To overcome this, we sought to establish a clinical grade culture system that can reproducibly generate antigen-specific cytotoxic T lymphocytes (CTL)., Experimental Design: We created an off-the-shelf, standardized, and renewable artificial antigen-presenting cell (aAPC) line that coexpresses HLA class I, CD54, CD58, CD80, and the dendritic cell maturation marker CD83. We tested the ability of aAPC to generate tumor antigen-specific CTL under optimal culture conditions. The number, phenotype, effector function, and in vitro longevity of generated CTL were determined., Results: Stimulation of CD8(+) T cells with peptide-pulsed aAPC generated large numbers of functional CTL that recognized a variety of tumor antigens. These CTLs, which possess a phenotype consistent with in vivo persistence, survived ex vivo for prolonged periods of time. Clinical grade aAPC(33), produced under current Good Manufacturing Practices guidelines, generated sufficient numbers of CTL within a short period of time. These CTL specifically lysed a variety of melanoma tumor lines naturally expressing a target melanoma antigen. Furthermore, antitumor CTL were easily generated in all melanoma patients examined., Conclusions: With clinical grade aAPC(33) in hand, we are now poised for clinical translation of ex vivo generated antitumor CTL for adoptive cell transfer.
- Published
- 2007
- Full Text
- View/download PDF
33. Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli.
- Author
-
Hägerkvist R, Mokhtari D, Lindholm C, Farnebo F, Mostoslavsky G, Mulligan RC, Welsh N, and Welsh M
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Animals, Cell Death, Cells, Cultured, Cisplatin toxicity, Humans, Phosphorylation, Proto-Oncogene Proteins genetics, Tunicamycin toxicity, Tyrosine metabolism, Adaptor Proteins, Signal Transducing metabolism, Apoptosis, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-abl metabolism
- Abstract
The adaptor protein Shb has previously been shown to regulate apoptosis in response to cytokines and inhibitors of angiogenesis although the mechanisms governing these effects have remained obscure. We currently demonstrate interactions between Shb and c-Abl and that Shb regulates c-Abl kinase activity. The data suggest that c-Abl binds to tyrosine phosphorylated Shb via a concerted effort involving both the c-Abl SH3 and SH2 domains. The biological significance of the Shb/c-Abl interaction was presently tested in overexpression experiments and was found to promote hydrogen peroxide-induced cell death. We also show by Shb knockdown experiments that Shb regulates c-Abl activity and modulates cell death in response to the genotoxic agent cisplatin and the endoplasmic reticulum stress-inducer tunicamycin. The findings are in agreement with the notion of Shb playing a pivotal role in modulating c-Abl pro-apoptotic signaling in response to various stress stimuli.
- Published
- 2007
- Full Text
- View/download PDF
34. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.
- Author
-
Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, and Mulligan RC
- Subjects
- Animals, Bone Marrow Transplantation adverse effects, Endonucleases, Genetic Therapy adverse effects, Humans, Immunologic Deficiency Syndromes pathology, Immunologic Deficiency Syndromes therapy, Lymphocytes immunology, Lymphocytes metabolism, Mice, Models, Genetic, Nuclear Proteins genetics, Genetic Vectors genetics, Immunologic Deficiency Syndromes genetics, Immunologic Deficiency Syndromes immunology, Lentivirus genetics, Nuclear Proteins immunology, Nuclear Proteins metabolism, Transgenes genetics
- Abstract
Artemis gene mutations are responsible for the development of a severe combined immunodeficiency [radiation-sensitive (RS) SCID] characterized by a severe B and T cell deficiency and a normal natural killer cell population. To establish the feasibility of a gene therapy approach to the treatment of RS-SCID, we generated a series of lentiviral vectors expressing human Artemis from different promoters and used them to transduce highly purified hematopoietic stem cells (HSCs) from Artemis knockout mice. HSCs transduced by the different viruses were transplanted into either lethally irradiated Rag-1-deficient animals or Artemis knockout mice treated with a nonmyeloablative dose of Busulfan. In both models, transplantation of HSCs transduced by a vector that used a murine phosphoglycerate kinase (PGK) promoter led to a complete functional correction of the immunodeficiency. Corrected animals displayed rescue of mature B cells with normal levels of serum immunoglobulins, together with complete rescue of the T cell compartment as evidenced by the presence of mature T lymphocytes in peripheral blood as well as normal values of thymocytes in thymus. Those B and T cells were capable of activation, as shown both by in vitro stimulation responses and in vivo after immune challenge. Overall, the results indicate that a gene therapy approach for RS-SCID involving the transplantation of genetically modified HSCs is indeed feasible. Furthermore, our studies suggest the possibility that nonmyeloablative conditioning regimens might be effectively used to promote engraftment of genetically modified cells in the case of diseases where standard irradiation-based myeloablative bone marrow transplantation protocols may prove problematic.
- Published
- 2006
- Full Text
- View/download PDF
35. Exogenous control of mammalian gene expression via modulation of translational termination.
- Author
-
Murphy GJ, Mostoslavsky G, Kotton DN, and Mulligan RC
- Subjects
- Acetanilides pharmacology, Aminobenzoates pharmacology, Aminoglycosides pharmacology, Animals, Cell Line, Cells, Cultured, Genetic Vectors, Gentamicins pharmacology, Luciferases biosynthesis, Mice, Peptide Chain Termination, Translational drug effects, Transgenes genetics, Codon, Terminator physiology, Gene Expression Regulation physiology, Genetic Engineering methods, Peptide Chain Termination, Translational physiology
- Abstract
Here, we describe a system for the exogenous control of gene expression in mammalian cells that relies on the control of translational termination. To achieve gene regulation, we modified protein-coding sequences by introduction of a translational termination codon just downstream from the initiator AUG codon. Translation of the resulting mRNA leads to potent reduction in expression of the desired gene product. Expression of the gene product can be controlled by treating cells that express the mRNA with either aminoglycoside antibiotics or several nonantibiotic compounds. We show that the extent of regulation of gene expression can be substantial (60-fold) and that regulation can be achieved in the case of a variety of different genes, in different cultured cell lines and in primary cells in vivo. This gene regulation strategy offers significant advantages over existing methods for controlling gene expression and should have both immediate experimental application and possible clinical application.
- Published
- 2006
- Full Text
- View/download PDF
36. VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis.
- Author
-
Tam BY, Wei K, Rudge JS, Hoffman J, Holash J, Park SK, Yuan J, Hefner C, Chartier C, Lee JS, Jiang S, Nayak NR, Kuypers FA, Ma L, Sundram U, Wu G, Garcia JA, Schrier SL, Maher JJ, Johnson RS, Yancopoulos GD, Mulligan RC, and Kuo CJ
- Subjects
- Animals, Hematocrit, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Hypoxia-Inducible Factor 1, alpha Subunit physiology, Mice, Mice, Inbred C57BL, Mice, SCID, Mice, Transgenic, Models, Animal, Polycythemia physiopathology, Receptors, Vascular Endothelial Growth Factor physiology, Retinal Vessels physiology, Erythropoietin physiology, Liver physiology, Vascular Endothelial Growth Factor A physiology
- Abstract
Vascular endothelial growth factor (VEGF) exerts crucial functions during pathological angiogenesis and normal physiology. We observed increased hematocrit (60-75%) after high-grade inhibition of VEGF by diverse methods, including adenoviral expression of soluble VEGF receptor (VEGFR) ectodomains, recombinant VEGF Trap protein and the VEGFR2-selective antibody DC101. Increased production of red blood cells (erythrocytosis) occurred in both mouse and primate models, and was associated with near-complete neutralization of VEGF corneal micropocket angiogenesis. High-grade inhibition of VEGF induced hepatic synthesis of erythropoietin (Epo, encoded by Epo) >40-fold through a HIF-1alpha-independent mechanism, in parallel with suppression of renal Epo mRNA. Studies using hepatocyte-specific deletion of the Vegfa gene and hepatocyte-endothelial cell cocultures indicated that blockade of VEGF induced hepatic Epo by interfering with homeostatic VEGFR2-dependent paracrine signaling involving interactions between hepatocytes and endothelial cells. These data indicate that VEGF is a previously unsuspected negative regulator of hepatic Epo synthesis and erythropoiesis and suggest that levels of Epo and erythrocytosis could represent noninvasive surrogate markers for stringent blockade of VEGF in vivo.
- Published
- 2006
- Full Text
- View/download PDF
37. Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.
- Author
-
Yen L, Magnier M, Weissleder R, Stockwell BR, and Mulligan RC
- Subjects
- Acridine Orange chemistry, Adenosine analogs & derivatives, Adenosine chemistry, Animals, Antibiotics, Antineoplastic pharmacology, Cell Line, Cytidine analogs & derivatives, Cytidine chemistry, Drug Evaluation, Preclinical, Ethidium chemistry, Fluorouracil pharmacology, Guanine analogs & derivatives, Guanine chemistry, Humans, Mice, Mice, Nude, Molecular Structure, Toyocamycin pharmacology, Tubercidin pharmacology, Uridine analogs & derivatives, Uridine chemistry, beta-Galactosidase metabolism, Enzyme Inhibitors chemistry, Gene Expression Regulation, Enzymologic, RNA, Catalytic antagonists & inhibitors
- Abstract
We have recently described an RNA-only gene regulation system for mammalian cells in which inhibition of self-cleavage of an mRNA carrying ribozyme sequences provides the basis for control of gene expression. An important proof of principle for that system was provided by demonstrating the ability of one specific small molecule inhibitor of RNA self-cleavage, toyocamycin, to control gene expression in vitro and vivo. Here, we describe the development of the high-throughput screening (HTS) assay that led to the identification of toyocamycin and other molecules capable of inhibiting RNA self-cleavage in mammalian cells. To identify small molecules that can serve as inhibitors of ribozyme self-cleavage, we established a cell-based assay in which expression of a luciferase (luc) reporter is controlled by ribozyme sequences, and screened 58,076 compounds for their ability to induce luciferase expression. Fifteen compounds able to inhibit ribozyme self-cleavage in cells were identified through this screen. The most potent of the inhibitors identified were toyocamycin and 5-fluorouridine (FUR), nucleoside analogs carrying modifications of the 7-position and 5-position of the purine or pyrimidine bases. Individually, these two compounds were able to induce gene expression of the ribozyme-controlled reporter approximately 365-fold and 110-fold, respectively. Studies of the mechanism of action of the ribozyme inhibitors indicate that the compounds must be incorporated into RNA in order to inhibit RNA self-cleavage.
- Published
- 2006
- Full Text
- View/download PDF
38. Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow.
- Author
-
Balazs AB, Fabian AJ, Esmon CT, and Mulligan RC
- Subjects
- Animals, Biomarkers, Endothelial Protein C Receptor, Gene Expression, Glycoproteins genetics, Graft Survival, Hematopoietic Stem Cell Transplantation, Mice, Mice, Inbred Strains, Receptors, Cell Surface, Bone Marrow Cells cytology, Glycoproteins analysis, Hematopoietic Stem Cells cytology
- Abstract
The hematopoietic stem cell (HSC) is a unique cell type found in bone marrow, which has the capacity for both self-renewal and differentiation into all blood lineages. The identification of genes expressed specifically in HSCs may help identify gene products vital to the control of self-renewal and/or differentiation, as well as antigens capable of forming the basis for improved methods of stem cell isolation. In previous studies, we identified a number of genes that appeared to be differentially expressed in murine bone marrow-derived HSCs, using microarray technology. We report here that one of those genes, encoding the murine endothelial protein C receptor (EPCR), is expressed at high levels within the bone marrow in HSCs. Bone marrow cells isolated on the basis of EPCR expression alone are highly enriched for hematopoietic reconstitution activity, showing levels of engraftment in vivo comparable to that of stem cells purified using the most effective conventional methods. Moreover, evaluation of cell populations first enriched for stem cell activity by conventional methods and subsequently fractionated on the basis of EPCR expression indicates that stem cell activity is always associated with EPCR-expressing cells. Based on our findings, we believe EPCR represents the first known marker that 'explicitly' identifies hematopoietic stem cells within murine bone marrow.
- Published
- 2006
- Full Text
- View/download PDF
39. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
- Author
-
Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, Kung AL, Mulligan RC, and Carter BS
- Subjects
- Animals, Brain Neoplasms drug therapy, Brain Neoplasms enzymology, Cell Line, Tumor, Gene Expression Regulation, Enzymologic physiology, Glioblastoma drug therapy, Glioblastoma enzymology, Humans, Longitudinal Studies, Luminescent Proteins biosynthesis, Luminescent Proteins genetics, Male, Mice, Mice, Nude, Angiogenesis Inhibitors therapeutic use, Brain Neoplasms diagnosis, Glioblastoma diagnosis, Luciferases, Firefly biosynthesis, Luciferases, Firefly genetics, Magnetic Resonance Imaging methods, Xenograft Model Antitumor Assays methods
- Abstract
Objective: Outcome studies in rodent tumor models rely on both histological and noninvasive study end points. Intracranial models require special tools to observe tumor growth over time noninvasively, such as magnetic resonance imaging (MRI), computed tomographic scanning, or cranial window techniques. These techniques share disadvantages in terms of cost, technical expertise required, and overall animal throughput for analysis. In this report, we sought to validate the use of the relatively newer technique of bioluminescence imaging (BLI) of intracranial glioblastoma xenograft growth by comparing it with gadolinium-enhanced MRI., Methods: U87MG glioma cell lines genetically engineered to express the firefly luciferase gene were stereotactically injected into nude mice in the left frontal lobe. Weekly BLI and MRI were performed after the inoculation of tumor cells. For BLI, tumor growth was assessed as the peak BLI after systemic injection of luciferin substrate. MRI-based growth curves were created by three-dimensional volumetric reconstruction of axial gadolinium-enhanced MRI data covering the whole brain. In a separate experiment, mice were treated with adenoviruses encoding antiangiogenic soluble vascular endothelial growth factor receptors, and treatment effect was monitored by BLI., Results: Untreated tumor growth was readily detected and observed over time by serial BLI measurements. Furthermore, tumor-derived light emission was highly correlated with volume of tumor as assessed by MRI. Furthermore, the tested antiangiogenic treatment effect was readily detected using this technique, suggesting the power of the technique for sensitive monitoring of novel therapeutics., Conclusion: BLI offers a simple and rapid technique for assessing intracranial glioblastoma growth in rodent models noninvasively, which correlates well with MRI. The speed of the BLI technique can increase experimental throughput, allows for targeted histological analysis in animals showing the greatest treatment effects, and provides new insights into the kinetics of intracranial tumor growth in the setting of different treatments.
- Published
- 2006
- Full Text
- View/download PDF
40. Failure of bone marrow to reconstitute lung epithelium.
- Author
-
Kotton DN, Fabian AJ, and Mulligan RC
- Subjects
- Animals, Bone Marrow Cells cytology, Cell Lineage, Epithelial Cells cytology, Genes, Reporter, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Hematopoietic Stem Cells cytology, Humans, Mice, Mice, Inbred C57BL, Mice, Transgenic, Peptides genetics, Peptides metabolism, Pulmonary Surfactant-Associated Protein C, Respiratory Mucosa cytology, Transplantation Chimera, Bone Marrow Cells physiology, Bone Marrow Transplantation, Epithelial Cells metabolism, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells physiology, Pulmonary Alveoli cytology, Respiratory Mucosa physiology
- Abstract
A new paradigm of epithelial tissue reconstitution has been suggested whereby circulating cells derived from bone marrow contribute to a variety of epithelial cell types. With regard to the lung, several recent reports have used immunofluorescence microscopy to demonstrate engraftment of bone marrow-derived cells as type II pneumocytes, the endogenous progenitors of the lung alveolus. We show here that immunofluorescence microscopy, as has been used in previous reports, cannot reliably identify rare engrafted cells in lung tissue sections after transplantation of bone marrow cells or purified hematopoietic stem cells tracked with ubiquitous labels. We have employed a lineage-specific reporter system based on transgenic mice that express the GFP reporter gene only in lung epithelial cells (surfactant protein C-GFP) to assay for engrafted cells by flow cytometry, histology, and molecular methods. Using this approach to evaluate transplant recipients, including those subjected to bleomycin-induced lung injury, we demonstrate that when autofluorescence, dead cells, and contaminating blood cells are excluded from analysis, there is no detectable reconstitution of lung alveolar epithelial cells by unfractionated bone marrow cells or purified hematopoietic stem cells.
- Published
- 2005
- Full Text
- View/download PDF
41. A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity.
- Author
-
Kotton DN, Fabian AJ, and Mulligan RC
- Subjects
- Animals, Bone Marrow immunology, Leukocyte Common Antigens immunology, Liver immunology, Mice, Mice, Inbred C57BL, Phenotype, Reverse Transcriptase Polymerase Chain Reaction, Transplantation, Heterologous immunology, Hematopoiesis immunology, Hematopoietic Stem Cells immunology, Liver cytology
- Abstract
A number of recent reports have documented that cells possessing hematopoietic-reconstitution ability can be identified and isolated from a variety of solid organs in the adult animal. In all studies to date, however, purified organ-derived stem cells demonstrate a diminished repopulating capacity relative to that of purified bone marrow-derived hematopoietic stem cells (BM HSCs). It has therefore been unclear whether organ-derived HSCs possess functional properties distinct from those of BM HSCs, or simply have not been purified to a comparable extent. Here we report the identification of a rare subset of cells in adult murine liver that possess potent blood-repopulating potential, approaching that of BM HSCs. The cells, isolated on the basis of dye-efflux activity and CD45 expression (termed CD45(+) liver side population [SP] tip cells), exhibit a surface phenotype similar to that of freshly isolated BM HSCs derived from normal adult animals, but are phenotypically distinct in that they do not express the stem-cell marker c-kit. Single-cell transplantation studies indicate that CD45(+) liver SP tip cells can be generated from BM HSCs, suggesting a relationship between stem-cell populations in the liver and bone marrow compartments. Overall, these studies have important implications for understanding extramedullary hematopoiesis, and may be relevant to current strategies aimed at inducing tolerance to transplanted organs.
- Published
- 2005
- Full Text
- View/download PDF
42. Engineering vascularized skeletal muscle tissue.
- Author
-
Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D'Amore PA, and Langer R
- Subjects
- Animals, Blood Vessels physiology, Cells, Cultured, Coculture Techniques, Embryo, Mammalian cytology, Endothelial Cells physiology, Endothelium, Vascular physiology, Fibroblasts physiology, Humans, Mice, Myoblasts, Skeletal physiology, Muscle, Skeletal blood supply, Neovascularization, Physiologic, Tissue Engineering methods
- Abstract
One of the major obstacles in engineering thick, complex tissues such as muscle is the need to vascularize the tissue in vitro. Vascularization in vitro could maintain cell viability during tissue growth, induce structural organization and promote vascularization upon implantation. Here we describe the induction of endothelial vessel networks in engineered skeletal muscle tissue constructs using a three-dimensional multiculture system consisting of myoblasts, embryonic fibroblasts and endothelial cells coseeded on highly porous, biodegradable polymer scaffolds. Analysis of the conditions for induction and stabilization of the vessels in vitro showed that addition of embryonic fibroblasts increased the levels of vascular endothelial growth factor expression in the construct and promoted formation and stabilization of the endothelial vessels. We studied the survival and vascularization of the engineered muscle implants in vivo in three different models. Prevascularization improved the vascularization, blood perfusion and survival of the muscle tissue constructs after transplantation.
- Published
- 2005
- Full Text
- View/download PDF
43. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.
- Author
-
Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, and Mulligan RC
- Subjects
- Animals, Cytokines pharmacology, Genetic Markers, Genetic Therapy adverse effects, Hematopoietic Stem Cells drug effects, Mice, Genetic Vectors genetics, Hematopoietic Stem Cell Transplantation, Lentivirus genetics, Proviruses genetics, Transduction, Genetic methods
- Abstract
The development of leukemias in several children with severe combined immunodeficiency disease who were transplanted with retroviral vector-transduced bone marrow cells has renewed concerns about the risks associated with the random integration of proviral sequences into chromosomal DNA. One theoretical way to reduce the risks of insertional mutagenesis would be to employ transduction/transplantation protocols that minimize the total number of genetically modified cells and associated proviral integration "events" introduced into recipients. Toward this end, we have developed a transduction protocol that involves the short-term incubation of highly purified murine stem cells with high-titer recombinant lentivirus vectors in the presence of serum-free medium and the cytokines SCF and TPO. Competitive repopulation studies showed that stem cells transduced in this way possessed the same reconstitutive ability as fresh, unmanipulated cells. Animals transplanted with only 200-2000 transduced cells were efficiently reconstituted with the genetically modified cells, and most hematopoietic cells in the recipients expressed the transgene. In contrast, the use of high-titer oncoretroviral vectors in conjunction with the same transduction/transplantation protocol resulted in only low levels of gene marking in vivo. The use of a similar transduction/transplantation strategy in future clinical studies may offer distinct advantages over current protocols.
- Published
- 2005
- Full Text
- View/download PDF
44. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
- Author
-
Fernandes JR, Duvivier-Kali VF, Keegan M, Hollister-Lock J, Omer A, Su S, Bonner-Weir S, Feng S, Lee JS, Mulligan RC, and Weir GC
- Subjects
- Abatacept, Animals, Antigens, CD, Antigens, Differentiation genetics, CTLA-4 Antigen, DNA analysis, Gene Expression, Genetic Vectors, Immunoconjugates genetics, Male, Mice, Mice, Inbred Strains, Models, Animal, RNA metabolism, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Transforming Growth Factor beta genetics, Adenoviridae genetics, Antigens, Differentiation pharmacology, Graft Survival drug effects, Immunoconjugates pharmacology, Immunosuppressive Agents pharmacology, Islets of Langerhans Transplantation, Lentivirus genetics, Transduction, Genetic, Transforming Growth Factor beta pharmacology
- Abstract
Background: A major problem facing islet transplantation is immune destruction of grafts by transplant rejection and autoimmunity. Some success in prolonging graft rejection has been obtained by transducing islets prior to transplantation with adenoviral (Ad) vectors containing CTLA4-Ig and TGFbeta. The purpose of this study was to see if lentiviral (LV) vectors would provide superior results compared with adenoviral vectors., Methods: Islets were isolated from Sprague-Dawley rats and transduced with Ad or LV vectors containing LacZ, CTLA4-Ig, CTLA4, and TGFbeta1 using various MOIs. Islets transduced with LV were healthy as judged by DNA and insulin content, and insulin secretion. Using the kidney capsule transplant site, 500 transduced rat islets were transplanted into streptozotocin diabetic B6AF1 mice., Results: Maintenance of normoglycemia was prolonged in recipient mice carrying islets transduced with Ad vectors containing CTLA4-Ig, CTLA4, and TGFbeta1. Return of hyperglycemia in controls was 17-18 days while loss of function for the experimental groups occurred at 20-27 days. For the lentivirus transduced islets, rejection of controls was 20+/-1.6 days, for CTLA4-Ig was 42+/-21 days and for TGFbeta was 28+/-3.2 days., Conclusions: Although islets transduced with either adenovirus or lentivirus containing CTLA4-Ig, CTLA4, and TGFbeta1 could prolong graft survival in a rat to mouse transplantation model, with the conditions of this study lentivirus provided no advantage over adenovirus vectors.
- Published
- 2004
- Full Text
- View/download PDF
45. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.
- Author
-
Yen L, Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, and Mulligan RC
- Subjects
- Adenosine pharmacology, Animals, Base Pairing, Base Sequence, Catalysis drug effects, Cell Line, Cell Line, Tumor, Cricetinae, Genes, Reporter genetics, Genetic Vectors genetics, Humans, Mice, Molecular Sequence Data, Oligonucleotides chemistry, Oligonucleotides genetics, Oligonucleotides metabolism, Oligonucleotides pharmacology, Organ Specificity, RNA, Catalytic chemistry, RNA, Catalytic genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Toyocamycin pharmacology, Gene Expression Regulation drug effects, Genetic Engineering methods, RNA, Catalytic antagonists & inhibitors, RNA, Catalytic metabolism
- Abstract
Recent studies on the control of specific metabolic pathways in bacteria have documented the existence of entirely RNA-based mechanisms for controlling gene expression. These mechanisms involve the modulation of translation, transcription termination or RNA self-cleavage through the direct interaction of specific intracellular metabolites and RNA sequences. Here we show that an analogous RNA-based gene regulation system can effectively be designed for mammalian cells via the incorporation of sequences encoding self-cleaving RNA motifs into the transcriptional unit of a gene or vector. When correctly positioned, the sequences lead to potent inhibition of gene or vector expression, owing to the spontaneous cleavage of the RNA transcript. Administration of either oligonucleotides complementary to regions of the self-cleaving motif or a specific small molecule results in the efficient induction of gene expression, owing to inhibition of self-cleavage of the messenger RNA. Efficient regulation of transgene expression is shown in a variety of mammalian cell lines and live animals. In conjunction with other emerging technologies, this methodology may be particularly applicable to the development of gene regulation systems tailored to any small inducer molecule, and provide a novel means of biological sensing in vivo that may have an important application in the regulated delivery of protein therapeutics.
- Published
- 2004
- Full Text
- View/download PDF
46. Dose-dependent response of FGF-2 for lymphangiogenesis.
- Author
-
Chang LK, Garcia-Cardeña G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, and Kaipainen A
- Subjects
- Animals, Cell Division drug effects, Cell Movement drug effects, Cornea blood supply, Cornea physiology, Corneal Neovascularization, Dose-Response Relationship, Drug, Endothelial Cells cytology, Endothelial Cells drug effects, Male, Mice, Mice, Inbred Strains, Neovascularization, Physiologic drug effects, Vascular Endothelial Growth Factor C pharmacology, Vascular Endothelial Growth Factor D pharmacology, Fibroblast Growth Factor 2 pharmacology, Lymphangiogenesis drug effects
- Abstract
Spatio-temporal studies on the growth of capillary blood vessels and capillary lymphatic vessels in tissue remodeling have suggested that lymphangiogenesis is angiogenesis-dependent. We revisited this concept by using fibroblast growth factor 2 (FGF-2) (80 ng) to stimulate the growth of both vessel types in the mouse cornea. When we lowered the dose of FGF-2 in the cornea 6.4-fold (12.5 ng), the primary response was lymphangiogenic. Further investigation revealed that vascular endothelial growth factor-C and -D are required for this apparent lymphangiogenic property of FGF-2, and when the small amount of accompanying angiogenesis was completely suppressed, lymphangiogenesis remained unaffected. Our findings demonstrate that there is a dose-dependent response of FGF-2 for lymphangiogenesis, and lymphangiogenesis can occur in the absence of a preexisting or developing vascular bed, i.e., in the absence of angiogenesis, in the mouse cornea.
- Published
- 2004
- Full Text
- View/download PDF
47. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
- Author
-
Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, and Sodroski J
- Subjects
- Amino Acid Substitution, Animals, Antiviral Restriction Factors, Carrier Proteins genetics, Carrier Proteins physiology, Cell Line, Cyclophilin A metabolism, Dose-Response Relationship, Drug, HIV drug effects, HIV genetics, HIV physiology, Humans, Infection Control, Macaca mulatta, Mice, Moloney murine leukemia virus drug effects, Retroviridae drug effects, Retroviridae physiology, Species Specificity, Transfection, Tripartite Motif Proteins, Ubiquitin-Protein Ligases, Carrier Proteins pharmacology, Moloney murine leukemia virus physiology
- Abstract
Murine leukemia viruses (MLVs) have been classified as N-tropic (N-MLV) or B-tropic (B-MLV), depending on their ability to infect particular mouse strains. The early phase of N-MLV infection is blocked in the cells of several mammalian species, including humans. This block is mediated by a dominant host factor that targets the viral capsid soon after virus entry into the cell has been achieved. A similar block to HIV-1 in rhesus monkey cells is mediated by TRIM5alpha. Here we show that human TRIM5alpha is both necessary and sufficient for the restriction of N-MLV in human cells. Rhesus monkey TRIM5alpha, which potently blocks HIV-1 infection, exhibited only modest inhibition of N-MLV infection. B-MLV was resistant to the antiviral effects of both human and rhesus monkey TRIM5alpha; susceptibility to TRIM5alpha-mediated restriction was conferred by alteration of residue 110 of the B-MLV capsid protein to the amino acid found in the N-MLV capsid. Our results demonstrate that species-specific variation in TRIM5alpha governs its ability to block infection by diverse retroviruses.
- Published
- 2004
- Full Text
- View/download PDF
48. Nitric oxide is a regulator of hematopoietic stem cell activity.
- Author
-
Michurina T, Krasnov P, Balazs A, Nakaya N, Vasilieva T, Kuzin B, Khrushchov N, Mulligan RC, and Enikolopov G
- Subjects
- Animals, Bone Marrow drug effects, Bone Marrow radiation effects, Bone Marrow Transplantation, Cell Proliferation, Enzyme Inhibitors pharmacology, Female, Gamma Rays, Gene Expression, Hematopoietic Stem Cells enzymology, Male, Mice, NG-Nitroarginine Methyl Ester pharmacology, Neutrophils physiology, Nitric Oxide Synthase genetics, Nitric Oxide Synthase metabolism, RNA, Messenger analysis, RNA, Messenger metabolism, Hematopoietic Stem Cells physiology, Nitric Oxide physiology, Nitric Oxide Synthase antagonists & inhibitors
- Abstract
Hematopoietic stem cells give rise to various multipotent progenitor populations, which expand in response to cytokines and which ultimately generate all of the elements of the blood. Here we show that it is possible to increase the number of stem and progenitor cells in the bone marrow (BM) by suppressing the activity of NO synthases (NOS). Exposure of mice to NOS inhibitors, either directly or after irradiation and BM transplantation, increases the number of stem cells in the BM. In the transplantation model, this increase is followed by a transient increase in the number of neutrophils in the peripheral blood. Thus, our results indicate that NO is important for the control of hematopoietic stem cells in the BM. They further suggest that suppression of NO synthase activity may allow expansion of the number of hematopoietic stem and progenitor cells or neutrophils for therapeutic purposes., (Copyright The American Society of Gene Therapy)
- Published
- 2004
- Full Text
- View/download PDF
49. Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.
- Author
-
Podar K, Mostoslavsky G, Sattler M, Tai YT, Hayashi T, Catley LP, Hideshima T, Mulligan RC, Chauhan D, and Anderson KC
- Subjects
- Adaptor Proteins, Signal Transducing, Cell Division, Cell Line, Tumor, Cell Survival, Humans, Multiple Myeloma enzymology, Mutagenesis, Phosphorylation, Phosphotyrosine metabolism, Protein-Tyrosine Kinases genetics, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins c-hck, Recombinant Proteins metabolism, Recombinant Proteins pharmacology, Signal Transduction, Interleukin-6 pharmacology, Multiple Myeloma pathology, Phosphoproteins metabolism, Protein-Tyrosine Kinases metabolism, Proto-Oncogene Proteins metabolism
- Abstract
Interleukin-6 (LI-6) is a known growth and survival factor in multiple myeloma via activation of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling cascade. In this report we show that Grb2-associated binder (Gab) family adapter proteins Gab1 and Gab2 are expressed by multiple myeloma cells; and that interleukin-6 induces their tyrosine phosphorylation and association with downstream signaling molecules. We further demonstrate that these events are Src family tyrosine kinase-dependent and specifically identify the role of hematopoietic cell kinase (Hck) as a new Gab family adapter protein kinase. Conversely, inhibition of Src family tyrosine kinases by the pyrazolopyrimidine PP2, as in kinase-inactive Hck mutants, significantly reduces IL-6-triggered activation of extracellular signal-regulated kinase and AKT-1, leading to significant reduction of multiple myeloma cell proliferation and survival. Taken together, these results delineate a key role for Hck-mediated phosphorylation of Gab1 and Gab2 docking proteins in IL-6-induced proliferation and survival of multiple myeloma cells and identify tyrosine kinases and downstream adapter proteins as potential new therapeutic targets in multiple myeloma.
- Published
- 2004
- Full Text
- View/download PDF
50. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells.
- Author
-
Matsuzaki Y, Kinjo K, Mulligan RC, and Okano H
- Subjects
- Animals, Antigens, CD34, Cell Differentiation physiology, Cell Division physiology, Cell Separation methods, Fluorescent Dyes, Hematopoietic Stem Cells physiology, Mice, Mice, Inbred C57BL, Phenotype, Staining and Labeling, Cell Movement, Graft Survival, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells cytology
- Abstract
Single-cell transplantation analysis revealed that the cells that had the strongest dye efflux activity ("Tip"-SP cells) and had the phenotype CD34- c-Kit+ Sca-1+ Lin- (CD34- KSL cells) exhibited very strong proliferation and multilineage differentiation capacity. Ninety-six percent of the lethally irradiated mice that received a single "Tip"-SP CD34- KSL cell showed significant donor cell engraftment for long term. These findings support the hypothesis that "Tip"-SP CD34- KSL cells represent the most primitive hematopoietic stem cells that are capable of migrating into the primary site and surviving and/or proliferating with nearly absolute efficiency. This led us to propose high marrow-seeding efficiency as a specific characteristic of primitive HSCs, in addition to their self-renewal and multipotent capacity.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.